Saint Luke's Newsroom

May. 19, 2021

KSHB: Woman says she owes her life to Saint Luke's breast cancer clinical trial

An Independence woman, diagnosed with stage 4 metastatic breast cancer, says she owes her life to a breast cancer clinical trial conducted at Saint Luke's Hospital.
Dr. John Spertus, director of health outcomes research at Saint Luke's Mid America Heart Institute
May. 18, 2021

Saint Luke’s Innovation Week Profile: Dr. John Spertus

Dr. John Spertus didn't choose medicine; medicine chose him.
May. 18, 2021

Saint Luke’s Cancer Institute Launches Innovative Digital Advocate for Advance Care Planning

Advance Care Appointment Companion is an intuitive digital advocate designed for patients to reflect on, create, and communicate their advance care plan with their care team and loved ones.
May. 18, 2021

Healio: DARE-19: No significant decrease in major events; dapagliflozin well treated in COVID-19

Dr. Mikhail Kosiborod presented findings of the DARE-19 Trial at the ACC Scientific Session.
Thumbnail
May. 18, 2021

Saint Luke’s Innovation Week Profile: Dr. Timothy Pluard

Dr. Timothy Pluard is a man on a mission. Growing up, Dr. Pluard always knew he wanted to be a doctor.
May. 17, 2021

Saint Luke’s Innovation Week Profile: Dr. Mikhail Kosiborod

Growing up in a medical family, Dr. Mikhail Kosiborod knew he wanted to be a physician from a young age.
May. 17, 2021

HCP Live: Heart Trials Podcast: DAPA-HF, with Mikhail Kosiborod, MD

Dr. Mikhail Kosiborod discusses the DAPA-HF trial, as well as the DARE-19 trial results, in this episode of HCP Live's Heart Trials podcast.
May. 17, 2021

Medpage Today: Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy

Dr. John Spertus reported the health status analysis of the EXPLORER-HCM Trial at the ACC Scientific Session.
May. 17, 2021

Healio: Marked health status improvement with mavacamten in obstructive hypertrophic cardiomyopathy

Dr. John Spertus presented new health status data from the EXPLORER-HCM Trial at the ACC Scientific Session.